Development and Validation of Ferroptosis- and Immune-Related lncRNAs Signatures for Breast Infiltrating Duct and Lobular Carcinoma

BACKGROUND: Heterogeneity of breast cancer (BRCA) is significantly correlated with its prognosis. Target therapy for ferroptosis and immunity is a new cancer treatment option discovered in recent years. In the present study, we aimed to identify ferroptosis- and immune-related long non-coding RNAs (...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Tao, Zhu, Ning, Jiang, Weihua, Xing, Xiao-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015165/
https://www.ncbi.nlm.nih.gov/pubmed/35444943
http://dx.doi.org/10.3389/fonc.2022.844642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015165/
https://www.ncbi.nlm.nih.gov/pubmed/35444943
http://dx.doi.org/10.3389/fonc.2022.844642

Ejemplares similares